You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – Sequenom today said that it has launched a certified service program for its MassArray System and has named the first laboratory participants.
NewGene has launched a sequencing-based test on Roche's 454 GS FLX for Noonan syndrome and other related disorders.
NewGene's hereditary breast cancer test
NewGene is initially targeting the UK market and patients with an increased hereditary risk for breast cancer for its pyrosequencing-based assay.
The UK firm will provide services for NimbleGen Sequence Capture Arrays with sequencing on Roche 454's Genome Sequencer FLX System.
The company expects to use Roche's 454 technology to offer full-gene sequencing tests at a lower cost and faster turnaround time than existing providers using Sanger sequencing.
David Huntley, Ann Curtis, Jonathan Robinson, Jonathan Coxhead, David Allison, John Burn, Michael Wright, Kary Mullis
Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.
Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.
A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.
In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.